Last reviewed · How we verify
GSK424887
At a glance
| Generic name | GSK424887 |
|---|---|
| Sponsor | GlaxoSmithKline |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- First Study in Humans With GSK424887 (PHASE1)
- Emotional Processing in Healthy Volunteers in the Presence of an Investigational Anxiolytic (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |